Nephrocare Health Services IPO allotment is likely finalizing today, December 15, 2025, after 14.08x subscription. GMP stands at ₹16 (3.48% premium over ₹460 upper band), hinting modest listing gains. Investors can verify status via Kfin, NSE/BSE portals.
The ₹871 crore mainboard IPO of Nephrocare Health Services, a dialysis care provider, opened December 10-12 at ₹438-460/share (lot: 32 shares). It drew strong QIB (24.2x) and NII (23.21x) bids, with anchors like top funds bidding ₹260 crore. Shares credit December 16, listing December 17 on NSE/BSE.
Key Highlights
Subscription Strength: Overall 14.08x; QIBs 24.2x, NII 23.21x, retail 1.64x—decent retail response amid healthcare demand.
GMP Indicator: ₹16 premium suggests ₹476 listing price, up 3.48% from top band; improved from zero earlier.
Fund Usage: Proceeds fund new clinics (₹129cr), debt repayment (₹136cr), corporate needs.
Step-by-Step Allotment Check
Kfin Tech: Visit kosmic.kfintech.com/ipostatus, select Nephrocare, enter PAN/app no./DP ID.
BSE: bseindia.com/investors/appl.html, pick Equity > Nephrocare > PAN/app no.
NSE: nseindia.com, Equity IPO > NEPHROPLUS > PAN/app no.
Refunds initiate tomorrow for non-allottees. Watch for listing pops in dialysis sector.
Sources: Business Standard, Chittorgarh, IPO Watch, NDTV Profit